Calcium/Calmodulin-Dependent Protein Kinase II Regulation of IKs during Sustained Beta-Adrenergic Receptor Stimulation

dc.contributor.authorShugg, Tyler
dc.contributor.authorJohnson, Derrick E.
dc.contributor.authorShao, Minghai
dc.contributor.authorLai, Xianyin
dc.contributor.authorWitzmann, Frank
dc.contributor.authorCummins, Theodore R.
dc.contributor.authorRubart-Von der Lohe, Michael
dc.contributor.authorHudmon, Andy
dc.contributor.authorOverholser, Brian R.
dc.contributor.departmentBiochemistry and Molecular Biology, School of Medicineen_US
dc.description.abstractBackground Sustained β-adrenergic receptor (β-AR) stimulation causes pathophysiological changes during heart failure (HF), including inhibition of the slow component of the delayed rectifier potassium current (IKs). Aberrant calcium handling, including increased activation of calcium/calmodulin-dependent protein kinase II (CaMKII), contributes to arrhythmia development during HF. Objective The purpose of this study was to investigate CaMKII regulation of KCNQ1 (pore-forming subunit of IKs) during sustained β-AR stimulation and associated functional implications on IKs. Methods KCNQ1 phosphorylation was assessed using LCMS/MS after sustained β-AR stimulation with isoproterenol (ISO). Peptide fragments corresponding to KCNQ1 residues were synthesized to identify CaMKII phosphorylation at the identified sites. Dephosphorylated (alanine) and phosphorylated (aspartic acid) mimics were introduced at identified residues. Whole-cell, voltage-clamp experiments were performed in human endothelial kidney 293 cells coexpressing wild-type or mutant KCNQ1 and KCNE1 (auxiliary subunit) during ISO treatment or lentiviral δCaMKII overexpression. Results Novel KCNQ1 carboxy-terminal sites were identified with enhanced phosphorylation during sustained β-AR stimulation at T482 and S484. S484 peptides demonstrated the strongest δCaMKII phosphorylation. Sustained β-AR stimulation reduced IKs activation (P = .02 vs control) similar to the phosphorylated mimic (P = .62 vs sustained β-AR). Individual phosphorylated mimics at S484 (P = .04) but not at T482 (P = .17) reduced IKs function. Treatment with CN21 (CaMKII inhibitor) reversed the reductions in IKs vs CN21-Alanine control (P < .01). δCaMKII overexpression reduced IKs similar to ISO treatment in wild type (P < .01) but not in the dephosphorylated S484 mimic (P = .99). Conclusion CaMKII regulates KCNQ1 at S484 during sustained β-AR stimulation to inhibit IKs. The ability of CaMKII to inhibit IKs may contribute to arrhythmogenicity during HF.en_US
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationShugg, T., Johnson, D. E., Shao, M., Lai, X., Witzmann, F., Cummins, T. R., … Overholser, B. R. (2018). Calcium/Calmodulin-Dependent Protein Kinase II Regulation of IKs during Sustained Beta-Adrenergic Receptor Stimulation. Heart Rhythm.
dc.relation.journalHeart Rhythmen_US
dc.rightsPublisher Policyen_US
dc.subjectcalcium/calmodulin-dependent protein kinase IIen_US
dc.subjectdelayed rectifieren_US
dc.titleCalcium/Calmodulin-Dependent Protein Kinase II Regulation of IKs during Sustained Beta-Adrenergic Receptor Stimulationen_US
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
1.13 MB
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
1.99 KB
Item-specific license agreed upon to submission